title: microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?
abstract: microRNA-10b (miR-10b) expression in pancreatic ductal adenocarcinoma (PDAC), as identified by in situ hybridization, is highly correlated with cancer diagnosis, therapy response, and prognosis. If these findings are further confirmed in prospective studies, miR-10b could be used to improve the management of PDAC and decrease the mortality rate of this deadly cancer.
authors.affiliation: Department of Experimental Therapeutics and Cancer Biology and Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Setoyama
authors.forename: Xinna
authors.initials: X
authors.lastname: Zhang
authors.forename: Shoji
authors.initials: S
authors.lastname: Natsugoe
authors.forename: George A
authors.initials: GA
authors.lastname: Calin
mesh_terms: D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
chemical_list: C547183:MIRN10 microRNA, human; D035683:MicroRNAs